Egis Pharmaceuticals Overview

  • Year Founded
  • 1913

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4,800

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 2

  • Investments
  • 3

Egis Pharmaceuticals General Information

Description

Developer of pharmaceutical products dedicated to the treatment of the cardiovascular system, central nervous system, gastroenterology, oncology and women's health. The company offers active ingredients, tablets and injections as well as galenic in liquid and semi-solid formulations.

Contact Information

Website
www.egis.hu
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Kereszturi Ut 30-38
  • Budapest, 1106
  • Hungary
+36 (06
Primary Industry
Pharmaceuticals
Parent Company
Corporate Office
  • Kereszturi Ut 30-38
  • Budapest, 1106
  • Hungary
+36 (06

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Egis Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Egis Pharmaceuticals‘s full profile, request access.

Request a free trial

Egis Pharmaceuticals Patents

Egis Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026009009-A1 Troriluzole hydrochloride salts Pending 05-Jul-2024
EP-4815954-A1 Process for the preparation of abrocitinib Pending 28-Nov-2023
WO-2025114733-A1 Process for the preparation of abrocitinib Inactive 28-Nov-2023
EP-4750763-A1 Blarcamesine co-crystals for the manufacture of pharmaceutical dosage form Pending 25-Jul-2023
US-12018005-B1 Blarcamesine co-crystals for the manufacture of pharmaceutical dosage form Active 25-Jul-2023 C07D307/14
To view Egis Pharmaceuticals’s complete patent history, request access »

Egis Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Egis Pharmaceuticals Investments & Acquisitions (3)

Egis Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Teva Pharmaceutical Industries (Manufacturing Rights of Topical Product Line in Hungary). The deal was made on 16-Dec-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Teva Pharmaceutical Industries (Manufacturing Rights of Topical Product Line in Hungary) 16-Dec-2024 Corporate Asset Purchase Buildings and Property
Jadran-Galenski Laboratorij (D-Panthenol brand) 02-Jun-2017 Corporate Asset Purchase Buildings and Property
Medimpex Hungary Merger/Acquisition Pharmaceuticals
To view Egis Pharmaceuticals’s complete investments and acquisitions history, request access »

Egis Pharmaceuticals FAQs

  • When was Egis Pharmaceuticals founded?

    Egis Pharmaceuticals was founded in 1913.

  • Where is Egis Pharmaceuticals headquartered?

    Egis Pharmaceuticals is headquartered in Budapest, Hungary.

  • What is the size of Egis Pharmaceuticals?

    Egis Pharmaceuticals has 4,800 total employees.

  • What industry is Egis Pharmaceuticals in?

    Egis Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Egis Pharmaceuticals a private or public company?

    Egis Pharmaceuticals is a Private company.

  • What is the current valuation of Egis Pharmaceuticals?

    The current valuation of Egis Pharmaceuticals is .

  • What is Egis Pharmaceuticals’s current revenue?

    The current revenue for Egis Pharmaceuticals is .

  • When was Egis Pharmaceuticals acquired?

    Egis Pharmaceuticals was acquired on 07-Nov-2013.

  • Who acquired Egis Pharmaceuticals?

    Egis Pharmaceuticals was acquired by Servier.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process